| Detected | Trial | Change |
|---|---|---|
| 2026-06-12 | NCT07328425 Clinical Study in Adult and Young Adult Patients With Advanced Desmoplastic Small Round… |
Trial sites expanded: 1 -> 5 locations |
| 2026-06-11 | NCT05083481 A Study of ASP1570 Taken by Itself, or ASP1570 Taken Together With Either Pembrolizumab… |
Trial terminated |
| 2026-06-11 | NCT05083481 A Study of ASP1570 Taken by Itself, or ASP1570 Taken Together With Either Pembrolizumab… |
date change Primary completion moved earlier: 2026-06-30 -> 2026-05-11 |
| 2026-06-11 | NCT05083481 A Study of ASP1570 Taken by Itself, or ASP1570 Taken Together With Either Pembrolizumab… |
date change Completion moved earlier: 2026-06-30 -> 2026-05-11 |
| 2026-06-10 | NCT07490301 A Study to Assess Intravenous (IV) Telisotuzumab Adizutecan in Combination With… |
Recruitment opened |
| 2026-06-10 | NCT07490301 A Study to Assess Intravenous (IV) Telisotuzumab Adizutecan in Combination With… |
Trial sites expanded: 0 -> 9 locations |
| 2026-06-06 | NCT06750094 A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in… |
Trial sites expanded: 241 -> 247 locations |
| 2026-06-05 | NCT05669339 AD HOC Trial: Artificial Intelligence-Based Drug Dosing In Hepatocellular Carcinoma |
date change Primary completion pushed: 2026-04 -> 2027-04 |
| 2026-06-05 | NCT05669339 AD HOC Trial: Artificial Intelligence-Based Drug Dosing In Hepatocellular Carcinoma |
date change Completion pushed: 2026-04 -> 2027-04 |
| 2026-06-05 | NCT07518147 A Study Comparing BL-M05D1 With the Investigator's Choice of Treatment Regimen in… |
Recruitment opened |
| 2026-06-04 | NCT04753879 Multi-agent Low Dose Chemotherapy GAX-CI Followed by Olaparib and Pembro in Metastatic… |
date change Primary completion moved earlier: 2026-12-01 -> 2026-07-01 |
| 2026-06-04 | NCT04753879 Multi-agent Low Dose Chemotherapy GAX-CI Followed by Olaparib and Pembro in Metastatic… |
date change Completion moved earlier: 2029-12-01 -> 2026-07-01 |
| 2026-05-28 | NCT06459180 A Study to Compare Sacituzumab Tirumotecan (MK-2870) Monotherapy Versus Treatment of… |
overall status: "Recruiting" → "Active Not Recruiting" |
| 2026-05-28 | NCT06346392 AZD0901 Compared With Investigator's Choice of Therapy in Participants With Second- or… |
overall status: "Recruiting" → "Active Not Recruiting" |
| 2026-05-28 | NCT06346392 AZD0901 Compared With Investigator's Choice of Therapy in Participants With Second- or… |
Trial sites reduced: 186 -> 158 locations |
| 2026-05-28 | NCT06346392 AZD0901 Compared With Investigator's Choice of Therapy in Participants With Second- or… |
date change Primary completion pushed: 2026-05-14 -> 2026-06-15 |
| 2026-05-28 | NCT06346392 AZD0901 Compared With Investigator's Choice of Therapy in Participants With Second- or… |
date change Completion pushed: 2026-09-14 -> 2026-10-14 |
| 2026-05-27 | NCT06607185 A Study of the Pan-KRAS Inhibitor LY4066434 in Participants With KRAS Mutant Solid Tumors |
Trial sites reduced: 56 -> 47 locations |
| 2026-05-23 | NCT05239741 Study of Pembrolizumab (MK-3475) Versus Chemotherapy in Chinese Participants With Stage… |
overall status: "Recruiting" → "Active Not Recruiting" |
| 2026-05-23 | NCT03715933 Phase 1 Study of INBRX-109 in Subjects With Locally Advanced or Metastatic Solid Tumors… |
Enrollment increased: 321 -> 411 participants |
| First Posted | Trial | Phase | Status |
|---|---|---|---|
| 2026-06-02 | NCT07619313 AB801 in Combination With Chemotherapy and Immunotherapy for the Treatment of Patients… | Phase 1 | Not Yet Recruiting |
| 2026-06-02 | NCT07621718 Study of Zoldonrasib + Chemo of Investigator's Choice vs Placebo + Chemo of… | Phase 3 | Recruiting |
| 2026-05-26 | NCT07606599 A Study of BL-M07D1 Versus Physician's Choice of Chemotherapy in Patients With… | Phase 3 | Not Yet Recruiting |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 4 | |||
| NCT07094893 | Anti-EGFR Agents in Patients With Right-sided Advanced Colorectal Cancer With Wild-type… | Colorectal Cancer | Not Yet Recruiting |
| Phase 3 | |||
| NCT06644781 | A Study of Ifinatamab Deruxtecan in Subjects With Pretreated Advanced or Metastatic… | Esophageal Squamous Cell Carcinoma | Recruiting |
| NCT04342910 | Study to Evaluate the Efficacy and Safety of Camrelizumab and Apatinib in Patients With… | Gastric Cancer | Recruiting |
| NCT07284134 | JS107 vs Investigator's Choice as Second-line or Later Therapy for Advanced… | Advanced Gastric or Gastroesophageal Junction Adenocarcinoma | Recruiting |
| NCT06951503 | AK112 and Chemotherapy in First-line Metastatic Colorectal Cancer | Colorectal Adenocarcinoma | Recruiting |
| NCT06958328 | Testing Higher Dose Radiation Therapy for Locally Advanced Pancreatic Cancer | Locally Advanced Unresectable Pancreatic Ductal Adenocarcinoma | Recruiting |
| NCT06401330 | A Study Using Risk Factors to Determine Treatment for Children With Favorable Histology… | Stage I Mixed Cell Type Kidney Wilms Tumor | Recruiting |
| NCT05677490 | mFOLFIRINOX Versus mFOLFOX With or Without Nivolumab for the Treatment of Advanced… | Advanced Esophageal Adenocarcinoma | Recruiting |
| NCT06998940 | Studying Chemotherapy With or Without Panitumumab for Unresectable, Locally Advanced, or… | Locally Advanced Pancreatic Adenocarcinoma | Recruiting |
| NCT05863195 | Testing Pump Chemotherapy in Addition to Standard of Care Chemotherapy Versus Standard of… | Metastatic Colorectal Carcinoma | Recruiting |
| NCT07409272 | A Study to Evaluate the Effectiveness and Safety of Setidegrasib, Given With Either… | Pancreatic Cancer | Recruiting |
| NCT07621718 | Study of Zoldonrasib + Chemo of Investigator's Choice vs Placebo + Chemo of… | Pancreatic Cancer | Recruiting |
| NCT07518147 | A Study Comparing BL-M05D1 With the Investigator's Choice of Treatment Regimen in… | Gastric Cancer | Recruiting |
| NCT03303495 | A Study of 2nd-line FOLFIRI ± Bevacizumab vs. Irinotecan ± Bevacizumab in mCRC | Colorectal Neoplasms | Recruiting |
| NCT06662786 | A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI… | Colorectal Neoplasms | Recruiting |
| NCT06750094 | A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in… | Colorectal Neoplasms | Recruiting |
| NCT06172296 | Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of… | Ganglioneuroblastoma, Nodular | Recruiting |
| NCT06351020 | LM-302 for the Treatment of Subjects With Claudin18.2-Positive Gastric and… | Locally Advanced or Metastatic GC and GCJ Adenocarcinoma | Active, Not Recruiting |
| NCT04340141 | Testing the Use of the Usual Chemotherapy Before and After Surgery for Removable… | Pancreatic Adenosquamous Carcinoma | Active, Not Recruiting |
| NCT06356311 | A Study to Evaluate Sacituzumab Tirumotecan (MK-2870) in Advanced/Metastatic… | Gastroesophageal Cancer | Active, Not Recruiting |
| NCT04094688 | Vitamin D3 With Chemotherapy and Bevacizumab in Treating Patients With Advanced or… | Colorectal Adenocarcinoma | Active, Not Recruiting |
| NCT07466316 | A Study Comparing Higher Dose Chemotherapy Over a Shorter Amount of Time to Lower Dose… | Rhabdomyosarcoma | Not Yet Recruiting |
| NCT07487896 | A Study of YL201 Versus Investigator's Choice of Chemotherapy in Participants With… | Advanced Esophageal Squamous Cell Carcinoma | Not Yet Recruiting |
| NCT06304974 | A Study Comparing BL-B01D1 With Chemotherapy of Physician's Choice in Patients With… | Esophageal Squamous Cell Carcinoma | Active, Not Recruiting |
| NCT00980460 | Risk-Based Therapy in Treating Younger Patients With Newly Diagnosed Liver Cancer | PRETEXT I Hepatoblastoma | Active, Not Recruiting |